Canaccord Genuity Reiterates a 'Buy' on Brightpoint (CELL); DOJ Suit to Block AT&T/T-Mobile Merger Potentially Beneficial
Tweet Send to a Friend
Canaccord Genuity reiterates a 'Buy' on Brightpoint (NASDAQ: CELL) price target of $14.00.
Canaccord analyst, T. Michael Walkley, said, "With ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst, T. Michael Walkley, said, "With ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
